Tag - EVGN

Developments

Evogene and BCDD collaborate in drug discovery initiative

Evogene (NASDAQ: EVGN; TASE: EVGN) and Tel Aviv University’s Blavatnik Center for Drug Discovery (BCDD) have announced a collaboration that aims to expedite the development of small-molecule drug discovery originating...

July 9, 2026

Developments

Evogene to develop next generation medical cannabis products

Evogene (NASDAQ, TASE:EVGN) has established a new subsidiary, Canonic, to develop next generation medical cannabis products. Evogene has been evaluating the medical cannabis field for more than a year, including market...

April 3, 2019

Tag - EVGN

Evogene and BCDD collaborate in drug discovery initiative

Evogene to develop next generation medical cannabis products

Subscribe